NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, 2025, NMD4C proudly hosted its first Clinical Summer School in Ottawa, ON, welcoming 19 neuromuscular clinical fellows from institutions across the country. Co-chaired by Dr. Gordon Jewitt and Dr. Marianne Nury, the event marked a significant milestone in national efforts to foster excellence in neuromuscular care and education.
The immersive two-day program featured interactive, hands-on workshops led by Canadian experts, including Drs. Alberto Aleman, Grayson Beecher, Ari Breiner, Leslie Hamilton, Hanns Lochmüller, Hugh McMillan, Gerd Melkus, Kiran Polavarapu, Zaeem Siddiqi, and Jodi Warman Chardon. These sessions were designed to complement NMD4C’s Royal College–accredited National Neuromuscular Lecture Series, offering fellows a unique opportunity to refine diagnostic and analytical skills in a collaborative setting.
In addition to clinical training, the Summer School emphasized mentorship and peer connection. A dedicated networking session on Day 1 allowed fellows to build relationships and share experiences, reinforcing the network’s commitment to community-building among early-career researchers.
A highlight of the event was the peer election of Dr. Joaquín Machado and Dr. Bridget Mulvany-Robbins as Co-Chief Neuromuscular Fellows. We also extend our thanks to Dr. Zahra Aleisa for her outstanding service and leadership as our 2024/2025 Chief Neuromuscular Fellow. Her commitment has been instrumental in shaping a supportive and enriching environment for fellows across the network.
To ensure accessibility, NMD4C waived registration fees and provided travel and accommodation support, enabling participation from across Canada. We would like to extend our thanks to our sponsors FUJIFILM Sonosite and CANON Medical, as well as all speakers, fellows, and partners whose contributions made the event a resounding success.
By investing in the next generation of neuromuscular specialists, NMD4C continues to advance its mission of collaborative research, clinical excellence, and national capacity-building in neuromuscular medicine.
Relive the highlights from this event
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.
NMD4C Launches Clinical Summer School
We are excited to announce our inaugural Clinical Summer School, happening in Ottawa, Ontario on September 10–11, 2025. The event will feature hands-on workshops designed to complement the NMD4C Royal College–accredited National Neuromuscular Lecture Series and foster engagement among fellows.